30 Participants NeededMy employer runs this trial

Exercise for Peripheral Neuropathy

(CYCLE-CIPN Trial)

TL
CS
Overseen ByChristopher Sellar, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Margie McNeely
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if regular cycling exercise can reduce symptoms of peripheral neuropathy (nerve damage) caused by chemotherapy. Participants will engage in supervised cycling sessions twice a week for 12 weeks to assess the practicality and impact on quality of life. The researchers seek individuals with mild peripheral neuropathy who have undergone chemotherapy for stage I to III cancer and are not currently participating in similar exercise programs. As an unphased trial, this study provides a unique opportunity to contribute to understanding how exercise might enhance life quality for those affected by chemotherapy-induced nerve damage.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this exercise intervention is safe for participants?

Research has shown that aerobic exercise, such as cycling, is safe for individuals with peripheral neuropathy. Studies have found that these exercises do not cause serious side effects. For example, cycling is safe for people with diabetes who have nerve damage and can even improve leg function. Participants in various studies, including those with diabetic nerve damage, reported no major problems from aerobic exercise. Stationary cycling is considered a safe and easy exercise option for those with nerve damage from chemotherapy. Overall, exercise is generally well-tolerated and effective for managing symptoms related to chemotherapy-induced nerve damage.12345

Why are researchers excited about this trial?

Researchers are excited about cycling-based aerobic exercise as a treatment for peripheral neuropathy because it offers a non-pharmaceutical approach that could improve nerve function and reduce symptoms without the side effects associated with medications. Unlike standard treatments that often involve pain relievers, antidepressants, or anticonvulsants, this exercise-based method focuses on enhancing blood flow and nerve health naturally. Additionally, aerobic exercise can potentially improve overall physical fitness and quality of life for patients, offering a holistic benefit beyond symptom management.

What evidence suggests that this aerobic exercise intervention is effective for reducing CIPN symptoms?

Research has shown that aerobic exercises, such as cycling, can alleviate symptoms for people with chemotherapy-induced peripheral neuropathy (CIPN). Cycling, in particular, improves blood flow in the legs and helps control blood sugar levels, both of which benefit neuropathy. A review of several studies concluded that exercise effectively reduces the severity of CIPN symptoms. Specifically, one study found that after an 8-week exercise program, participants experienced less pain and a moderate reduction in neuropathy symptoms. This trial will specifically evaluate the effectiveness of a cycling-based aerobic exercise intervention for managing and reducing CIPN symptoms.23678

Who Is on the Research Team?

ML

Margaret L McNeely, PhD

Principal Investigator

University of Alberta

Are You a Good Fit for This Trial?

This trial is for adults (18+) with stage I-III cancer who have mild nerve symptoms from chemotherapy (CIPN). Participants must be able to speak, read, and understand English. They can be currently receiving or have finished chemotherapy.

Inclusion Criteria

I am 18 years old or older.
My cancer is diagnosed at stage I, II, or III.
I have mild nerve damage from chemotherapy.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants engage in a 12-week stationary cycling-based aerobic exercise program

12 weeks
24 visits (in-person, biweekly)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Cycling-Based Aerobic Exercise Intervention

Trial Overview

The study tests whether a supervised stationary cycling exercise program done twice a week for 12 weeks can help reduce nerve-related symptoms caused by chemotherapy. The focus is on safety, participation rates, and symptom improvement.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Aerobic exercise interventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Margie McNeely

Lead Sponsor

Trials
1
Recruited
30+

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Cross Cancer Institute

Collaborator

Trials
62
Recruited
19,200+

Citations

Effectiveness of a Therapeutic Exercise Program to Improve ...

The exercises were highly effective in improving pain threshold and moderately effective in improving peripheral neuropathy symptoms at the 8-week follow-up ...

Cycle Training improves vascular function and neuropathic ...

Cycling training can significantly improve lower limb vascular function in patients with DPN. Cycling training can improve glycemic control and neuropathic ...

Cycling-Based Aerobic Exercise Intervention for Individuals ...

The study will also evaluate CIPN symptoms using both patient-reported and objective outcome measures, as well as fitness and quality of life ...

Exercise for people with peripheral neuropathy - PMC - NIH

There is inadequate evidence to evaluate the effect of exercise on functional ability in people with peripheral neuropathy. The results suggest that progressive ...

Effectiveness of Exercise and Physiotherapy in ...

Both exercise and physiotherapy interventions were effective, safe, and feasible for the management of chemotherapy-induced peripheral neuropathy (CIPN). The ...

Safety of Aerobic Exercise in People With Diabetic Peripheral ...

Several large-scale randomized controlled trials have established that aerobic exercise improves physical fitness, glycemic control, and insulin sensitivity in ...

Impact of Exercise Training in Patients with Diabetic ... - PMC

Exercise plays a key role in enhancing glycemic control and nerve function, reducing the risk of DPN and related complications.

(PDF) Safety of Aerobic Exercise in People With Diabetic ...

The study confirms aerobic exercise is feasible for people with diabetic peripheral neuropathy (DPN) without serious adverse events.